{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:33:16Z","timestamp":1788910396797,"version":"build-2803163510"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s12016-021-08902-0","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T12:02:45Z","timestamp":1632312165000},"page":"216-231","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Combining Anti-IgE Monoclonal Antibodies and Oral Immunotherapy for the Treatment of Food Allergy"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7344-8290","authenticated-orcid":false,"given":"Laurent","family":"Guilleminault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Michelet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3384-6769","authenticated-orcid":false,"given":"Laurent Lionel","family":"Reber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,22]]},"reference":[{"key":"8902_CR1","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/all.13319","volume":"73","author":"GB Pajno","year":"2018","unstructured":"Pajno GB, Fernandez-Rivas M, Arasi S, Roberts G, Akdis CA, Alvaro-Lozano M, Beyer K, Bindslev-Jensen C, Burks W, Ebisawa M, Eigenmann P, Knol E, Nadeau KC, Poulsen LK, van Ree R, Santos AF, du T G, Dhami S, Nurmatov U, Boloh Y, Makela M, O\u2019Mahony L, Papadopoulos N, Sackesen C, Agache I, Angier E, Halken S, Jutel M, Lau S, Pfaar O, Ryan D, Sturn G, Varga EM, van Wijk RG, Sheikh A, Muraro A (2018) EAACI Guidelines on allergen immunotherapy: IgE-mediated food\u00a0allergy. Allergy 73:799\u2013815. https:\/\/doi.org\/10.1111\/all.13319","journal-title":"Allergy"},{"key":"8902_CR2","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/imj.13362","volume":"47","author":"ML Tang","year":"2017","unstructured":"Tang ML, Mullins RJ (2017) Food allergy: is prevalence increasing? Intern Med J 47:256\u2013261. https:\/\/doi.org\/10.1111\/imj.13362","journal-title":"Intern Med J"},{"key":"8902_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jaad.2010.11.020","volume":"64","author":"JA Boyce","year":"2011","unstructured":"Boyce JA, Assa\u2019ad A, Burks AW, Jones SM, Sampson HA, Wood RA, Plaut M, Cooper SF, Fenton MJ, Arshad SH (2011) Guidelines for the diagnosis and management of food allergy in the United\u00a0States: summary of the NIAID-sponsored expert panel report. J Am Acad Dermatol 64:175\u2013192","journal-title":"J Am Acad Dermatol"},{"key":"8902_CR4","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1001\/jama.2010.582","volume":"303","author":"JJ Chafen","year":"2010","unstructured":"Chafen JJ, Newberry SJ, Riedl MA, Bravata DM, Maglione M, Suttorp MJ, Sundaram V, Paige NM, Towfigh A, Hulley BJ, Shekelle PG (2010) Diagnosing and managing common food allergies: a\u00a0systematic review. Jama 303:1848\u201356. https:\/\/doi.org\/10.1001\/jama.2010.582","journal-title":"Jama"},{"key":"8902_CR5","doi-asserted-by":"publisher","first-page":"100080","DOI":"10.1016\/j.waojou.2019.100080","volume":"13","author":"IJ Ansotegui","year":"2020","unstructured":"Ansotegui IJ, Melioli G, Canonica GW, Caraballo L, Villa E, Ebisawa M, Passalacqua G, Savi E, Ebo D, G\u00f3mez RM, Luengo S\u00e1nchez O, Oppenheimer JJ, Jensen-Jarolim E, Fischer DA, Haahtela T, Antila M, Bousquet JJ, Cardona V, Chiang WC, Demoly PM, DuBuske LM, Ferrer Puga M, Gerth van Wijk R, Gonz\u00e1lez D\u00edaz SN, Gonzalez-Estrada A, Jares E, Kalpaklio\u011flu AF, Kase Tanno L, Kowalski ML, Ledford DK, Monge Ortega OP, Morais Almeida M, Pfaar O, Poulsen LK, Pawankar R, Renz HE, Romano AG, Ros\u00e1rio Filho NA, Rosenwasser L, S\u00e1nchez Borges MA, Scala E, Senna GE, Sisul JC, Tang MLK, Thong BY, Valenta R, Wood RA, Zuberbier T (2020) IgE allergy diagnostics and other\u00a0relevant tests in allergy, a World Allergy Organization position paper. World Allergy Organ J 13:100080. https:\/\/doi.org\/10.1016\/j.waojou.2019.100080","journal-title":"World Allergy Organ J"},{"key":"8902_CR6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/all.12305","volume":"69","author":"BI Nwaru","year":"2014","unstructured":"Nwaru BI, Hickstein L, Panesar SS, Muraro A, Werfel T, Cardona V, Dubois AE, Halken S, Hoffmann-Sommergruber K, Poulsen LK, Roberts G, Van Ree R, Vlieg-Boerstra BJ, Sheikh A (2014) The 570 epidemiology of food allergy in Europe: a systematic review and meta-analysis. Allergy 69:62\u201375. https:\/\/doi.org\/10.1111\/all.12305","journal-title":"Allergy"},{"key":"8902_CR7","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1111\/all.12423","volume":"69","author":"BI Nwaru","year":"2014","unstructured":"Nwaru BI, Hickstein L, Panesar SS, Roberts G, Muraro A, Sheikh A (2014) Prevalence of common\u00a0food allergies in Europe: a systematic review and meta-analysis. Allergy 69:992\u20131007. https:\/\/doi.org\/10.1111\/all.12423","journal-title":"Allergy"},{"key":"8902_CR8","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1111\/all.13717","volume":"74","author":"G Pouessel","year":"2019","unstructured":"Pouessel G, Beaudouin E, Tanno LK, Drouet M, Deschildre A, Labreuche J, Renaudin JM (2019) Food-related anaphylaxis fatalities: analysis of the Allergy Vigilance Network(\u00ae) database. Allergy 74:1193\u20131196. https:\/\/doi.org\/10.1111\/all.13717","journal-title":"Allergy"},{"key":"8902_CR9","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.jaci.2015.11.015","volume":"137","author":"LB Grabenhenrich","year":"2016","unstructured":"Grabenhenrich LB, D\u00f6lle S, Moneret-Vautrin A, K\u00f6hli A, Lange L, Spindler T, Ru\u00ebff F, Nemat K, Maris I, Roumpedaki E, Scherer K, Ott H, Reese T, Mustakov T, Lang R, Fernandez-Rivas M, Kowalski ML, Bil\u00f2 MB, Hourihane JO, Papadopoulos NG, Beyer K, Muraro A, Worm M (2016) Anaphylaxis in children and adolescents: the European Anaphylaxis Registry. J Allergy Clin Immunol 137:1128-1137.e1. https:\/\/doi.org\/10.1016\/j.jaci.2015.11.015","journal-title":"J Allergy Clin Immunol"},{"key":"8902_CR10","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.jaip.2017.06.031","volume":"5","author":"PJ Turner","year":"2017","unstructured":"Turner PJ, Jerschow E, Umasunthar T, Lin R, Campbell DE, Boyle RJ (2017) Fatal anaphylaxis:\u00a0mortality rate and risk factors. J Allergy Clin Immunol Pract 5:1169\u20131178. https:\/\/doi.org\/10.1016\/j.jaip.2017.06.031","journal-title":"J Allergy Clin Immunol Pract"},{"key":"8902_CR11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/ACI.0b013e3283464cf0","volume":"11","author":"JA Lieberman","year":"2011","unstructured":"Lieberman JA, Sicherer SH (2011) Quality of life in food allergy. Curr Opin Allergy Clin Immunol 11:236\u201342. https:\/\/doi.org\/10.1097\/ACI.0b013e3283464cf0","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"8902_CR12","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/s1081-1206(10)62258-2","volume":"87","author":"SH Sicherer","year":"2001","unstructured":"Sicherer SH, Noone SA, Mu\u00f1oz-Furlong A (2001) The impact of childhood food allergy on quality of\u00a0life. Ann Allergy Asthma Immunol 87:461\u20134. https:\/\/doi.org\/10.1016\/s1081-1206(10)62258-2","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8902_CR13","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1398-9995.2008.01843.x","volume":"64","author":"RM King","year":"2009","unstructured":"King RM, Knibb RC, Hourihane JO (2009) Impact of peanut allergy on quality of life, stress and\u00a0anxiety in the family. Allergy 64:461\u20138. https:\/\/doi.org\/10.1111\/j.1398-9995.2008.01843.x","journal-title":"Allergy"},{"key":"8902_CR14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/ACI.0b013e3283464c74","volume":"11","author":"BK Ballmer-Weber","year":"2011","unstructured":"Ballmer-Weber BK, Hoffmann-Sommergruber K (2011) Molecular diagnosis of fruit and vegetable allergy. Curr Opin Allergy Clin Immunol 11:229\u201335. https:\/\/doi.org\/10.1097\/ACI.0b013e3283464c74","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"8902_CR15","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1111\/all.14082","volume":"74","author":"T Eiwegger","year":"2019","unstructured":"Eiwegger T, Hung L, San Diego KE, O\u2019Mahony L, Upton J (2019) Recent developments and highlights in food allergy. Allergy 74:2355\u20132367. https:\/\/doi.org\/10.1111\/all.14082","journal-title":"Allergy"},{"key":"8902_CR16","doi-asserted-by":"publisher","first-page":"366","DOI":"10.2500\/aap.2019.40.4248","volume":"40","author":"G Patel","year":"2019","unstructured":"Patel G, Saltoun C (2019) Skin testing in allergy. Allergy Asthma Proc 40:366\u2013368. https:\/\/doi.org\/10.2500\/aap.2019.40.4248","journal-title":"Allergy Asthma Proc"},{"key":"8902_CR17","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s11882-012-0318-8","volume":"13","author":"R Treudler","year":"2013","unstructured":"Treudler R, Simon JC (2013) Overview of component resolved diagnostics. Curr Allergy Asthma Rep 13:110\u20137. https:\/\/doi.org\/10.1007\/s11882-012-0318-8","journal-title":"Curr Allergy Asthma Rep"},{"key":"8902_CR18","doi-asserted-by":"publisher","unstructured":"Sicherer SH, Sampson HA (2014) Food allergy: epidemiology, pathogenesis, diagnosis, and\u00a0treatment. J Allergy Clin Immunol 133:291\u2013307; quiz 308. https:\/\/doi.org\/10.1016\/j.jaci.2013.11.020","DOI":"10.1016\/j.jaci.2013.11.020"},{"key":"8902_CR19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/all.12530","volume":"70","author":"K Beyer","year":"2015","unstructured":"Beyer K, Grabenhenrich L, H\u00e4rtl M, Beder A, Kalb B, Ziegert M, Finger A, Harandi N, Schlags R, Gappa M, Puzzo L, R\u00f6blitz H, Millner-Uhlemann M, B\u00fcsing S, Ott H, Lange L, Niggemann B (2015) Predictive values of component-specific IgE for the outcome of peanut and hazelnut food challenges in\u00a0children. Allergy 70:90\u20138. https:\/\/doi.org\/10.1111\/all.12530","journal-title":"Allergy"},{"key":"8902_CR20","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jaci.2012.05.019","volume":"130","author":"A Asarnoj","year":"2012","unstructured":"Asarnoj A, Nilsson C, Lidholm J, Glaumann S, \u00d6stblom E, Hedlin G, van Hage M, Lilja G, Wickman M (2012) Peanut component Ara h 8 sensitization and tolerance to peanut. J Allergy Clin Immunol 130:468\u201372. https:\/\/doi.org\/10.1016\/j.jaci.2012.05.019","journal-title":"J Allergy Clin Immunol"},{"key":"8902_CR21","doi-asserted-by":"publisher","unstructured":"Canonica GW, Ansotegui IJ, Pawankar R, Schmid-Grendelmeier P, van Hage M, Baena-Cagnani CE, Melioli G, Nunes C, Passalacqua G, Rosenwasser L, Sampson H, Sastre J, Bousquet J, Zuberbier T; WAO-ARIA-GA2LEN Task Force: Allen K, Asero r, Bohle B, Cox L, de Blay F, Ebisawa M, Maximiliano-Gomez R, Gonzalez-Diaz S , Haahtela T, Holgate S, Jakob T, Larche M, Matricardi PM, Oppenheimer J, Poulsen LK, Renz HE, Rosario N, Rothenberg M, Sanchez-Borges M, Scala E, Valenta R (2013) A WAO - ARIA - GA\u00b2LEN consensus document on molecularbased allergy diagnostics. World Allergy Organ J 6(1):17. https:\/\/doi.org\/10.1186\/1939-4551-6-17. PMID: 24090398; PMCID: PMC3874689","DOI":"10.1186\/1939-4551-6-17"},{"key":"8902_CR22","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1067\/mai.2001.114708","volume":"107","author":"HA Sampson","year":"2001","unstructured":"Sampson HA (2001) Utility of food-specific IgE concentrations in predicting symptomatic food allergy. J Allergy Clin Immunol 107:891\u20136. https:\/\/doi.org\/10.1067\/mai.2001.114708","journal-title":"J Allergy Clin Immunol"},{"key":"8902_CR23","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.jaci.2005.02.038","volume":"115","author":"G Roberts","year":"2005","unstructured":"Roberts G, Lack G (2005) Diagnosing peanut allergy with skin prick and specific IgE testing. J Allergy Clin Immunol 115:1291\u20136. https:\/\/doi.org\/10.1016\/j.jaci.2005.02.038","journal-title":"J Allergy Clin Immunol"},{"key":"8902_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11882-015-0534-0","volume":"15","author":"KS Tuano","year":"2015","unstructured":"Tuano KS, Davis CM (2015) Utility of component-resolved diagnostics in food allergy. Curr Allergy Asthma Rep 15:32. https:\/\/doi.org\/10.1007\/s11882-015-0534-0","journal-title":"Curr Allergy Asthma Rep"},{"key":"8902_CR25","doi-asserted-by":"publisher","unstructured":"Lawrence MG, Woodfolk JA, Schuyler AJ, Stillman LC, Chapman MD, Platts-Mills TA (2017) Half-life of IgE in serum and skin: consequences for anti-IgE therapy in patients with allergic disease. J Allergy Clin Immunol 139:422-428.e4. https:\/\/doi.org\/10.1016\/j.jaci.2016.04.056","DOI":"10.1016\/j.jaci.2016.04.056"},{"key":"8902_CR26","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.immuni.2009.03.003","volume":"30","author":"N Fazilleau","year":"2009","unstructured":"Fazilleau N, Mark L, McHeyzer-Williams LJ, McHeyzer-Williams MG (2009) Follicular helper T cells: lineage and location. Immunity 30:324\u201335. https:\/\/doi.org\/10.1016\/j.immuni.2009.03.003","journal-title":"Immunity"},{"key":"8902_CR27","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1111\/all.14318","volume":"75","author":"CA Akdis","year":"2020","unstructured":"Akdis CA, Arkwright PD, Bruggen MC, Busse W, Gadina M, Guttman-Yassky E, Kabashima K, Mitamura Y, Vian L, Wu J, Palomares O (2020) Type 2 immunity in the skin and lungs. Allergy 75:1582\u20131605. https:\/\/doi.org\/10.1111\/all.14318","journal-title":"Allergy"},{"key":"8902_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nri.2017.118","volume":"18","author":"JA Walker","year":"2018","unstructured":"Walker JA, McKenzie ANJ (2018) TH2 cell development and function. Nat Rev Immunol 18:121\u2013133. https:\/\/doi.org\/10.1038\/nri.2017.118","journal-title":"Nat Rev Immunol"},{"key":"8902_CR29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1146\/annurev-immunol-051116-052350","volume":"35","author":"T Nakayama","year":"2017","unstructured":"Nakayama T, Hirahara K, Onodera A, Endo Y, Hosokawa H, Shinoda K, Tumes DJ, Okamoto Y (2017) Th2 cells in health and disease. Annu Rev Immunol 35:53\u201384. https:\/\/doi.org\/10.1146\/annurev-immunol-051116-052350","journal-title":"Annu Rev Immunol"},{"key":"8902_CR30","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jaci.2017.06.003","volume":"140","author":"LL Reber","year":"2017","unstructured":"Reber LL, Hernandez JD, Galli SJ (2017) The pathophysiology of anaphylaxis. J Allergy Clin Immunol 140:335\u2013348. https:\/\/doi.org\/10.1016\/j.jaci.2017.06.003","journal-title":"J Allergy Clin Immunol"},{"key":"8902_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1146\/annurev-immunol-071719-094903","volume":"38","author":"SJ Galli","year":"2020","unstructured":"Galli SJ, Gaudenzio N, Tsai M (2020) Mast cells in inflammation and disease: recent progress and ongoing concerns. Annu Rev Immunol 38:49\u201377. https:\/\/doi.org\/10.1146\/annurev-immunol-071719-094903","journal-title":"Annu Rev Immunol"},{"key":"8902_CR32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ejphar.2015.05.070","volume":"778","author":"U Blank","year":"2016","unstructured":"Blank U, Charles N, Benhamou M (2016) The high-affinity immunoglobulin E receptor as pharmacological target. Eur J Pharmacol 778:24\u201332. https:\/\/doi.org\/10.1016\/j.ejphar.2015.05.070","journal-title":"Eur J Pharmacol"},{"key":"8902_CR33","first-page":"351","volume":"30","author":"L Golberg","year":"1978","unstructured":"Golberg L (1978) Toxicology: has a new era dawned? Pharmacol Rev 30:351\u201370","journal-title":"Pharmacol Rev"},{"key":"8902_CR34","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/87603","volume":"8","author":"JM McDonnell","year":"2001","unstructured":"McDonnell JM, Calvert R, Beavil RL, Beavil AJ, Henry AJ, Sutton BJ, Gould HJ, Cowburn D (2001) The structure of the IgE Cepsilon2 domain and its role in stabilizing the complex with its high-affinity receptor FcepsilonRIalpha. Nat Struct Biol 8:437\u201341. https:\/\/doi.org\/10.1038\/87603","journal-title":"Nat Struct Biol"},{"key":"8902_CR35","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.4049\/jimmunol.151.5.2623","volume":"151","author":"LG Presta","year":"1993","unstructured":"Presta LG, Lahr SJ, Shields RL, Porter JP, Gorman CM, Fendly BM, Jardieu PM (1993) Humanization of an antibody directed against IgE. J Immunol 151:2623\u201332","journal-title":"J Immunol"},{"key":"8902_CR36","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa1009705","volume":"364","author":"WW Busse","year":"2011","unstructured":"Busse WW, Morgan WJ, Gergen PJ, Mitchell HE, Gern JE, Liu AH, Gruchalla RS, Kattan M, Teach SJ, Pongracic JA, Chmiel JF, Steinbach SF, Calatroni A, Togias A, Thompson KM, Szefler SJ, Sorkness CA (2011) Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med 364:1005\u201315. https:\/\/doi.org\/10.1056\/NEJMoa1009705","journal-title":"N Engl J Med"},{"key":"8902_CR37","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.jaci.2017.06.032","volume":"141","author":"M Maurer","year":"2018","unstructured":"Maurer M, Metz M, Brehler R, Hillen U, Jakob T, Mahler V, Pf\u00f6hler C, Staubach P, Treudler R, Wedi B, Magerl M (2018) Omalizumab treatment in patients with chronic inducible urticaria: A\u00a0systematic review of published evidence. J Allergy Clin Immunol 141:638\u2013649. https:\/\/doi.org\/10.1016\/j.jaci.2017.06.032","journal-title":"J Allergy Clin Immunol"},{"key":"8902_CR38","doi-asserted-by":"publisher","unstructured":"Kolkhir P, Church MK, Weller K, Metz M, Schmetzer O, Maurer M (2017) Autoimmune chronic spontaneous urticaria: What we know and what we do not know. J Allergy Clin Immunol 139:1772-1781.e1. https:\/\/doi.org\/10.1016\/j.jaci.2016.08.050","DOI":"10.1016\/j.jaci.2016.08.050"},{"key":"8902_CR39","doi-asserted-by":"publisher","first-page":"11581","DOI":"10.1038\/srep11581","volume":"5","author":"JD Wright","year":"2015","unstructured":"Wright JD, Chu HM, Huang CH, Ma C, Chang TW, Lim C (2015) Structural and physical basis for anti-IgE therapy. Sci Rep 5:11581. https:\/\/doi.org\/10.1038\/srep11581","journal-title":"Sci Rep"},{"key":"8902_CR40","doi-asserted-by":"publisher","first-page":"9975","DOI":"10.1074\/jbc.M117.776476","volume":"292","author":"AM Davies","year":"2017","unstructured":"Davies AM, Allan EG, Keeble AH, Delgado J, Cossins BP, Mitropoulou AN, Pang MOY, Ceska T, Beavil AJ, Craggs G, Westwood M, Henry AJ, McDonnell JM, Sutton BJ (2017) Allosteric mechanism of action of the therapeutic anti-IgE antibody omalizumab. J Biol Chem 292:9975\u20139987. https:\/\/doi.org\/10.1074\/jbc.M117.776476","journal-title":"J Biol Chem"},{"key":"8902_CR41","doi-asserted-by":"publisher","first-page":"11610","DOI":"10.1038\/ncomms11610","volume":"7","author":"LF Pennington","year":"2016","unstructured":"Pennington LF, Tarchevskaya S, Brigger D, Sathiyamoorthy K, Graham MT, Nadeau KC, Eggel A, Jardetzky TS (2016) Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange. Nat Commun 7:11610. https:\/\/doi.org\/10.1038\/ncomms11610","journal-title":"Nat Commun"},{"key":"8902_CR42","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nbt0290-122","volume":"8","author":"TW Chang","year":"1990","unstructured":"Chang TW, Davis FM, Sun NC, Sun CR, MacGlashan DW, Hamilton RG Jr (1990) Monoclonal antibodies specific for human IgE-producing B cells: a potential therapeutic for IgE-mediated allergic diseases. Biotechnology (N Y) 8:122\u20136. https:\/\/doi.org\/10.1038\/nbt0290-122","journal-title":"Biotechnology (N Y)"},{"key":"8902_CR43","unstructured":"First biologic for allergy-related asthma (2003\u00a0Sep-Oct) FDA Consum 37(5):5. PMID: 14666890"},{"key":"8902_CR44","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1398-9995.2004.00772.x","volume":"60","author":"M Humbert","year":"2005","unstructured":"Humbert M, Beasley R, Ayres J, Slavin R, H\u00e9bert J, Bousquet J, Beeh KM, Ramos S, Canonica GW, Hedgecock S, Fox H, Blogg M, Surrey K (2005) Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy 60:309\u201316. https:\/\/doi.org\/10.1111\/j.1398-9995.2004.00772.x","journal-title":"Allergy"},{"key":"8902_CR45","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1111\/cea.12400","volume":"44","author":"JP Arm","year":"2014","unstructured":"Arm JP, Bottoli I, Skerjanec A, Floch D, Groenewegen A, Maahs S, Owen CE, Jones I, Lowe PJ (2014) Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects. Clin Exp Allergy 44:1371\u201385. https:\/\/doi.org\/10.1111\/cea.12400","journal-title":"Clin Exp Allergy"},{"key":"8902_CR46","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41467-019-13815-w","volume":"11","author":"P Gasser","year":"2020","unstructured":"Gasser P, Tarchevskaya SS, Guntern P, Brigger D, Ruppli R, Zbaren N, Kleinboelting S, Heusser C, Jardetzky TS, Eggel A (2020) The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab. Nat Commun 11:165. https:\/\/doi.org\/10.1038\/s41467-019-13815-w","journal-title":"Nat Commun"},{"key":"8902_CR47","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1056\/NEJMoa1900408","volume":"381","author":"M Maurer","year":"2019","unstructured":"Maurer M, Gim\u00e9nez-Arnau AM, Sussman G, Metz M, Baker DR, Bauer A, Bernstein JA, Brehler R, Chu CY, Chung WH, Danilycheva I, Grattan C, H\u00e9bert J, Katelaris C, Makris M, Meshkova R, Savic S, Sinclair R, Sitz K, Staubach P, Wedi B, L\u00f6ffler J, Barve A, Kobayashi K, Hua E, Severin T, Janocha R (2019) Ligelizumab for chronic spontaneous urticaria. N Engl J Med 381:1321\u20131332. https:\/\/doi.org\/10.1056\/NEJMoa1900408","journal-title":"N Engl J Med"},{"key":"8902_CR48","unstructured":"Novartis ligelizumab (QGE031) receives FDA Breakthrough Therapy designation for patients with chronic spontaneous urticaria (CSU) (n.d.) Novartis. https:\/\/www.novartis.com\/news\/media-releases\/novartis-ligelizumabqge031-receives-fda-breakthrough-therapy-designation-patients-chronic-spontaneous-urticaria-csu (accessed September 21, 2021)"},{"key":"8902_CR49","doi-asserted-by":"publisher","unstructured":"Vickery BP, Chin S, Burks AW (2011) Pathophysiology of food allergy. Pediatr Clin North Am 58:363\u201376, ix\u2013x. https:\/\/doi.org\/10.1016\/j.pcl.2011.02.012","DOI":"10.1016\/j.pcl.2011.02.012"},{"key":"8902_CR50","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1385\/criai:29:1:017","volume":"29","author":"VS Mankad","year":"2005","unstructured":"Mankad VS, Burks AW (2005) Omalizumab\u202f: other indications and unanswered questions. Clin Rev Allergy Immunol 29:17\u201330. https:\/\/doi.org\/10.1385\/criai:29:1:017","journal-title":"Clin Rev Allergy Immunol"},{"key":"8902_CR51","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1111\/all.12437","volume":"69","author":"A Muraro","year":"2014","unstructured":"Muraro A, Roberts G, Worm M, Bilo MB, Brockow K, Fernandez Rivas M, Santos AF, Zolkipli ZQ, Bellou A, Beyer K, Bindslev-Jensen C, Cardona V, Clark AT, Demoly P, Dubois AE, DunnGalvin A, Eigenmann P, Halken S, Harada L, Lack G, Jutel M, Niggemann B, Rueff F, Timmermans F, Vlieg-Boerstra BJ, Werfel T, Dhami S, Panesar S, Akdis CA, Sheikh A (2014) Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy 69:1026\u201345. https:\/\/doi.org\/10.1111\/all.12437","journal-title":"Allergy"},{"key":"8902_CR52","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1111\/all.12429","volume":"69","author":"A Muraro","year":"2014","unstructured":"Muraro A, Werfel T, Hoffmann-Sommergruber K, Roberts G, Beyer K, Bindslev-Jensen C, Cardona V, Dubois A, duToit G, Eigenmann P, Fernandez Rivas M, Halken S, Hickstein L, Host A, Knol E, Lack G, Marchisotto MJ, Niggemann B, Nwaru BI, Papadopoulos NG, Poulsen LK, Santos AF, Skypala I, Schoepfer A, Van Ree R, Venter C, Worm M, Vlieg-Boerstra B, Panesar S, de Silva D, Soares-Weiser K, Sheikh A, Ballmer-Weber BK, Nilsson C, de Jong NW, Akdis CA (2014) EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy 69:1008\u201325. https:\/\/doi.org\/10.1111\/all.12429","journal-title":"Allergy"},{"key":"8902_CR53","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1111\/all.12441","volume":"69","author":"A Muraro","year":"2014","unstructured":"Muraro A, Agache I, Clark A, Sheikh A, Roberts G, Akdis CA, Borrego LM, Higgs J, Hourihane JO, Jorgensen P, Mazon A, Parmigiani D, Said M, Schnadt S, van Os-Medendorp H, Vlieg-Boerstra BJ, Wickman M (2014) EAACI food allergy and anaphylaxis guidelines: managing patients with food allergy in the community. Allergy 69:1046\u201357. https:\/\/doi.org\/10.1111\/all.12441","journal-title":"Allergy"},{"key":"8902_CR54","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1111\/all.12453","volume":"69","author":"A Muraro","year":"2014","unstructured":"Muraro A, Hoffmann-Sommergruber K, Holzhauser T, Poulsen LK, Gowland MH, Akdis CA, Mills EN, Papadopoulos N, Roberts G, Schnadt S, van Ree R, Sheikh A, Vieths S (2014) EAACI Food Allergy and Anaphylaxis Guidelines. Protecting consumers with food allergies: understanding food consumption, meeting regulations and identifying unmet needs. Allergy 69:1464\u201372. https:\/\/doi.org\/10.1111\/all.12453","journal-title":"Allergy"},{"key":"8902_CR55","doi-asserted-by":"publisher","first-page":"e12824","DOI":"10.1111\/sji.12824","volume":"91","author":"C Costa","year":"2020","unstructured":"Costa C, Coimbra A, Vitor A, Aguiar R, Ferreira AL, Todo-Bom A (2020) Food allergy-From food avoidance to active treatment. Scand J Immunol 91:e12824. https:\/\/doi.org\/10.1111\/sji.12824","journal-title":"Scand J Immunol"},{"key":"8902_CR56","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/s1081-1206(10)60908-8","volume":"96","author":"ME Bollinger","year":"2006","unstructured":"Bollinger ME, Dahlquist LM, Mudd K, Sonntag C, Dillinger L, McKenna K (2006) The impact of food allergy on the daily activities of children and their families. Ann Allergy Asthma Immunol 96:415\u201321. https:\/\/doi.org\/10.1016\/s1081-1206(10)60908-8","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8902_CR57","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.anai.2019.01.014","volume":"122","author":"LA Bilaver","year":"2019","unstructured":"Bilaver LA, Chadha AS, Doshi P, O\u2019Dwyer L, Gupta RS (2019) Economic burden of food allergy: a systematic review. Ann Allergy Asthma Immunol 122:373-380.e1. https:\/\/doi.org\/10.1016\/j.anai.2019.01.014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8902_CR58","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/mi.2010.21","volume":"3","author":"AM Scurlock","year":"2010","unstructured":"Scurlock AM, Vickery BP, Hourihane JO, Burks AW (2010) Pediatric food allergy and mucosal tolerance. Mucosal Immunol 3:345\u201354. https:\/\/doi.org\/10.1038\/mi.2010.21","journal-title":"Mucosal Immunol"},{"key":"8902_CR59","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.coi.2016.08.002","volume":"42","author":"DM Hussey Freeland","year":"2016","unstructured":"Hussey Freeland DM, Fan-Minogue H, Spergel JM, Chatila TA, Nadeau KC (2016) Advances in food allergy oral immunotherapy: toward tolerance. Curr Opin Immunol 42:119\u2013123. https:\/\/doi.org\/10.1016\/j.coi.2016.08.002","journal-title":"Curr Opin Immunol"},{"key":"8902_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaci.2017.11.004","volume":"141","author":"AW Burks","year":"2018","unstructured":"Burks AW, Sampson HA, Plaut M, Lack G, Akdis CA (2018) Treatment for food allergy. J Allergy Clin Immunol 141:1\u20139. https:\/\/doi.org\/10.1016\/j.jaci.2017.11.004","journal-title":"J Allergy Clin Immunol"},{"key":"8902_CR61","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jaci.2010.12.1111","volume":"127","author":"P Varshney","year":"2011","unstructured":"Varshney P, Jones SM, Scurlock AM, Perry TT, Kemper A, Steele P, Hiegel A, Kamilaris J, Carlisle S, Yue X, Kulis M, Pons L, Vickery B, Burks AW (2011) A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol 127:654\u201360. https:\/\/doi.org\/10.1016\/j.jaci.2010.12.1111","journal-title":"J Allergy Clin Immunol"},{"key":"8902_CR62","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1056\/NEJMoa1200435","volume":"367","author":"AW Burks","year":"2012","unstructured":"Burks AW, Jones SM, Wood RA, Fleischer DM, Sicherer SH, Lindblad RW, Stablein D, Henning AK, Vickery BP, Liu AH, Scurlock AM, Shreffler WG, Plaut M, Sampson HA (2012) Oral immunotherapy for treatment of egg allergy in children. N Engl J Med 367:233\u201343. https:\/\/doi.org\/10.1056\/NEJMoa1200435","journal-title":"N Engl J Med"},{"key":"8902_CR63","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1056\/NEJMoa022613","volume":"348","author":"DY Leung","year":"2003","unstructured":"Leung DY, Sampson HA, Yunginger JW, Burks AW Jr, Schneider LC, Wortel CH, Davis FM, Hyun JD, Shanahan WR Jr (2003) Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med 348:986\u201393. https:\/\/doi.org\/10.1056\/NEJMoa022613","journal-title":"N Engl J Med"},{"key":"8902_CR64","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1093\/protein\/6.8.971","volume":"6","author":"F Kolbinger","year":"1993","unstructured":"Kolbinger F, Saldanha J, Hardman N, Bendig MM (1993) Humanization of a mouse anti-human IgE antibody: a potential therapeutic for IgE-mediated allergies. Protein\u00a0Eng 6:971\u201380. https:\/\/doi.org\/10.1093\/protein\/6.8.971","journal-title":"Protein\u00a0Eng"},{"key":"8902_CR65","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/72601","volume":"18","author":"TW Chang","year":"2000","unstructured":"Chang TW (2000) The pharmacological basis of anti-IgE therapy. Nat Biotechnol 18:157\u201362. https:\/\/doi.org\/10.1038\/72601","journal-title":"Nat Biotechnol"},{"key":"8902_CR66","doi-asserted-by":"publisher","first-page":"76","DOI":"10.2500\/aap.2010.31.3304","volume":"31","author":"A Rafi","year":"2010","unstructured":"Rafi A, Do LT, Katz R, Sheinkopf LE, Simons CW, Klaustermeyer W (2010) Effects of omalizumab in patients with food allergy. Allergy Asthma Proc 31:76\u201383. https:\/\/doi.org\/10.2500\/aap.2010.31.3304","journal-title":"Allergy Asthma Proc"},{"key":"8902_CR67","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.jaci.2011.01.051","volume":"127","author":"HA Sampson","year":"2011","unstructured":"Sampson HA, Leung DY, Burks AW, Lack G, Bahna SL, Jones SM, Wong DA (2011) A phase II, randomized, doubleblind, parallelgroup, placebocontrolled oral food challenge trial of Xolair (omalizumab) in peanut allergy. J Allergy Clin Immunol 127:1309\u201310.e1. https:\/\/doi.org\/10.1016\/j.jaci.2011.01.051","journal-title":"J Allergy Clin Immunol"},{"key":"8902_CR68","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.iac.2011.11.004","volume":"32","author":"KC Nadeau","year":"2012","unstructured":"Nadeau KC, Kohli A, Iyengar S, DeKruyff RH, Umetsu DT (2012) Oral immunotherapy and anti-IgE antibody-adjunctive treatment for food allergy. Immunol Allergy Clin North Am 32:111\u201333. https:\/\/doi.org\/10.1016\/j.iac.2011.11.004","journal-title":"Immunol Allergy Clin North Am"},{"key":"8902_CR69","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.jaci.2013.09.046","volume":"132","author":"LC Schneider","year":"2013","unstructured":"Schneider LC, Rachid R, LeBovidge J, Blood E, Mittal M, Umetsu DT (2013) A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients. J Allergy Clin Immunol 132:1368\u201374. https:\/\/doi.org\/10.1016\/j.jaci.2013.09.046","journal-title":"J Allergy Clin Immunol"},{"key":"8902_CR70","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.jaci.2016.08.010","volume":"139","author":"AJ MacGinnitie","year":"2017","unstructured":"MacGinnitie AJ, Rachid R, Gragg H, Little SV, Lakin P, Cianferoni A, Heimall J, Makhija M, Robison R, Chinthrajah RS, Lee J, Lebovidge J, Dominguez T, Rooney C, Lewis MO, Koss J, Burke-Roberts E, Chin K, Logvinenko T, Pongracic JA, Umetsu DT, Spergel J, Nadeau KC, Schneider LC (2017) Omalizumab facilitates rapid oral desensitization for peanut allergy. J Allergy Clin Immunol 139:873-881.e8. https:\/\/doi.org\/10.1016\/j.jaci.2016.08.010","journal-title":"J Allergy Clin Immunol"},{"key":"8902_CR71","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.jaci.2011.04.009","volume":"127","author":"KC Nadeau","year":"2011","unstructured":"Nadeau KC, Schneider LC, Hoyte L, Borras I, Umetsu DT (2011) Rapid oral desensitization in combination with omalizumab therapy in patients with cow\u2019s milk allergy. J Allergy Clin Immunol 127:1622\u20134. https:\/\/doi.org\/10.1016\/j.jaci.2011.04.009","journal-title":"J Allergy Clin Immunol"},{"key":"8902_CR72","doi-asserted-by":"publisher","first-page":"17453","DOI":"10.1038\/s41598-017-16730-6","volume":"7","author":"M Takahashi","year":"2017","unstructured":"Takahashi M, Soejima K, Taniuchi S, Hatano Y, Yamanouchi S, Ishikawa H, Irahara M, Sasaki Y, Kido H, Kaneko K (2017) Oral immunotherapy combined with omalizumab for high-risk cow\u2019s milk allergy: a randomized controlled trial. Sci Rep 7:17453. https:\/\/doi.org\/10.1038\/s41598-017-16730-6","journal-title":"Sci Rep"},{"key":"8902_CR73","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.jaci.2015.10.005","volume":"137","author":"RA Wood","year":"2016","unstructured":"Wood RA, Kim JS, Lindblad R, Nadeau K, Henning AK, Dawson P, Plaut M, Sampson HA (2016) A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow\u2019s milk allergy. J Allergy Clin Immunol 137:1103\u20131110. https:\/\/doi.org\/10.1016\/j.jaci.2015.10.005","journal-title":"J Allergy Clin Immunol"},{"key":"8902_CR74","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1710-1492-10-7","volume":"10","author":"P Begin","year":"2014","unstructured":"Begin P, Dominguez T, Wilson SP, Bacal L, Mehrotra A, Kausch B, Trela A, Tavassoli M, Hoyte E, O\u2019Riordan G, Blakemore A, Seki S, Hamilton RG, Nadeau KC (2014) Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using omalizumab. Allergy Asthma Clin Immunol 10:7. https:\/\/doi.org\/10.1186\/1710-1492-10-7","journal-title":"Allergy Asthma Clin Immunol"},{"key":"8902_CR75","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13223-017-0223-8","volume":"13","author":"S Andorf","year":"2017","unstructured":"Andorf S, Manohar M, Dominguez T, Bloc W, Tupa D, Kshirsagar RA, Sampath V, Chinthrajah RS, Nadeau KC (2017) Observational long-term follow-up study of rapid food oral immunotherapy with omalizumab. Allergy Asthma Clin Immunol 13:51. https:\/\/doi.org\/10.1186\/s13223-017-0223-8","journal-title":"Allergy Asthma Clin Immunol"},{"key":"8902_CR76","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1710-1492-10-25","volume":"10","author":"IM Otani","year":"2014","unstructured":"Otani IM, Begin P, Kearney C, Dominguez TL, Mehrotra A, Bacal LR, Wilson S, Nadeau K (2014) Multiple-allergen oral immunotherapy improves quality of life in caregivers of food-allergic pediatric\u00a0subjects. Allergy Asthma Clin Immunol 10:25. https:\/\/doi.org\/10.1186\/1710-1492-10-25","journal-title":"Allergy Asthma Clin Immunol"},{"key":"8902_CR77","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/s2468-1253(17)30392-8","volume":"3","author":"S Andorf","year":"2018","unstructured":"Andorf S, Purington N, Block WM, Long AJ, Tupa D, Brittain E, Rudman Spergel A, Desai M, Galli SJ, Nadeau KC, Chinthrajah RS (2018) Anti-IgE treatment with oral immunotherapy in multifood\u00a0allergic participants: a double-blind, randomised, controlled trial. Lancet Gastroenterol Hepatol 3:85\u201394. https:\/\/doi.org\/10.1016\/s2468-1253(17)30392-8","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"8902_CR78","doi-asserted-by":"publisher","DOI":"10.1111\/all.14833","author":"M Manohar","year":"2021","unstructured":"Manohar M, Dunham D, Gupta s, Yan Z, Zhang W, Minnicozzi S, Kirkey M, Bunning B, Chowdhury RR, Galli SJ, Boyd SD, Kost LE, Chinthrajah RS, Desai M, Oettgen HC, Maecker HT, Yu W, DeKruyff RH, Andorf S, Nadeau KC (2021) Immune changes beyond Th2 pathways during rapid\u00a0multifood immunotherapy enabled with omalizumab. Allergy. https:\/\/doi.org\/10.1111\/all.14833","journal-title":"Allergy"},{"key":"8902_CR79","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.eclinm.2018.12.006","volume":"7","author":"S Andorf","year":"2019","unstructured":"Andorf S, Purington N, Kumar D, Long A, O\u2019Laughlin KL, Sicherer S, Sampson H, Cianferoni A, Whitehorn TB, Petroni D, Makhija M, Robison RG, Lierl M, Logsdon S, Desai M, Galli SJ, Rael E, Assa\u2019ad A, Chinthrajah S, Pongracic J, Spergel JM, Tam J, Tilles S, Wang J, Nadeau K (2019) A phase 2\u00a0randomized controlled multisite study using omalizumab-facilitated rapid desensitization to test continued vs\u00a0discontinued dosing in multifood allergic individuals. E Clinical Medicine 7:27\u201338. https:\/\/doi.org\/10.1016\/j.eclinm.2018.12.006","journal-title":"E Clinical Medicine"},{"key":"8902_CR80","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/pai.12259","volume":"25","author":"I Lafuente","year":"2014","unstructured":"Lafuente I, Mazon A, Nieto M, Uixera S, Pina R, Nieto A (2014) Possible recurrence of symptoms\u00a0after discontinuation of omalizumab in anti-IgE-assisted desensitization to egg. Pediatr Allergy Immunol 25:717\u20139. https:\/\/doi.org\/10.1111\/pai.12259","journal-title":"Pediatr Allergy Immunol"},{"key":"8902_CR81","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/pai.12567","volume":"27","author":"C Martorell-Calatayud","year":"2016","unstructured":"Martorell-Calatayud C, Michavila-Gomez A, Martorell-Aragones A, Molini-Menchon N, Cerda-Mir JC, Felix-Toledo R, De Las Marinas-Alvarez MD (2016) Anti-IgE-assisted desensitization to egg and cow\u2019s milk in patients refractory to conventional oral immunotherapy. Pediatr Allergy Immunol 27:544\u20136. https:\/\/doi.org\/10.1111\/pai.12567","journal-title":"Pediatr Allergy Immunol"},{"key":"8902_CR82","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/j.1445-5994.2009.01967.x","volume":"39","author":"J Yun","year":"2009","unstructured":"Yun J, Katelaris CH (2009) Food allergy in adolescents and adults. Intern Med J 39:475\u20138. https:\/\/doi.org\/10.1111\/j.1445-5994.2009.01967.x","journal-title":"Intern Med J"},{"key":"8902_CR83","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.jaci.2014.04.040","volume":"134","author":"EC McGowan","year":"2014","unstructured":"McGowan EC, Savage JH, Courneya JP, Sterba PM, Parihar S, Lin J, Gimenez G, Sampson HA, Schroeder J, MacGlashan D, Wood RA, Hamilton RG, Saini S (2014) Relationship of IgE to basophil phenotypes in peanut-sensitized adults. J Allergy Clin Immunol 134:746\u2013749. https:\/\/doi.org\/10.1016\/j.jaci.2014.04.040","journal-title":"J Allergy Clin Immunol"},{"key":"8902_CR84","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13223-015-0084-y","volume":"11","author":"M Takahashi","year":"2015","unstructured":"Takahashi M, Taniuchi S, Soejima K, Hatano Y, Yamanouchi S, Kaneko K (2015) Successful desensitization in a boy with severe cow\u2019s milk allergy by a combination therapy using omalizumab and rush\u00a0oral immunotherapy. Allergy Asthma Clin Immunol 11:18. https:\/\/doi.org\/10.1186\/s13223-015-0084-y","journal-title":"Allergy Asthma Clin Immunol"},{"key":"8902_CR85","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.anai.2018.10.024","volume":"122","author":"AJ Stranks","year":"2019","unstructured":"Stranks AJ, Minnicozzi SC, Miller SJ, Burton OT, Logsdon SL, Spergel JM, Nadeau KC, Pongracic JA, Umetsu DT, Rachid R, MacGinnitie AJ, Schneider LC, Oettgen HC (2019) Immunoglobulin E blockade during food allergen ingestion enhances the induction of inhibitory immunoglobulin G antibodies. Ann Allergy Asthma Immunol 122:213\u2013215. https:\/\/doi.org\/10.1016\/j.anai.2018.10.024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8902_CR86","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1111\/cea.13469","volume":"49","author":"J Brandstrom","year":"2019","unstructured":"Brandstrom J, Vetander M, Sundqvist AC, Lilja G, Johansson SGO, Melen E, Sverremark-Ekstrom E, Nopp A, Nilsson C (2019) Individually dosed omalizumab facilitates peanut oral immunotherapy in peanut allergic adolescents. Clin Exp Allergy 49:1328\u20131341. https:\/\/doi.org\/10.1111\/cea.13469","journal-title":"Clin Exp Allergy"},{"key":"8902_CR87","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1398-9995.2006.00987.x","volume":"61","author":"A Nopp","year":"2006","unstructured":"Nopp A, Johansson SG, Ankerst J, Bylin G, Cardell LO, Gr\u00f6nneberg R, Irander K, Palmqvist M, Oman H (2006) Basophil allergen threshold sensitivity: a useful approach to anti-IgE treatment efficacy evaluation. Allergy 61:298\u2013302. https:\/\/doi.org\/10.1111\/j.1398-9995.2006.00987.x","journal-title":"Allergy"},{"key":"8902_CR88","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jaci.2018.10.028","volume":"143","author":"M Suarez-Farinas","year":"2019","unstructured":"Suarez-Farinas M, Suprun M, Chang HL, Gimenez G, Grishina G, Getts R, Nadeau K, Wood RA, Sampson HA (2019) Predicting development of sustained unresponsiveness to milk oral immunotherapy using epitope-specific antibody binding profiles. J Allergy Clin Immunol 143:1038\u20131046. https:\/\/doi.org\/10.1016\/j.jaci.2018.10.028","journal-title":"J Allergy Clin Immunol"},{"key":"8902_CR89","doi-asserted-by":"publisher","unstructured":"Siracusa MC, Kim BS, Spergel JM, Artis D (2013) Basophils and allergic inflammation. J Allergy Clin Immunol 132:789\u2013801; quiz 788. https:\/\/doi.org\/10.1016\/j.jaci.2013.07.046","DOI":"10.1016\/j.jaci.2013.07.046"},{"key":"8902_CR90","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.jaci.2012.05.038","volume":"130","author":"DW MacGlashan Jr","year":"2012","unstructured":"MacGlashan DW Jr, Savage JH, Wood RA, Saini SS (2012) Suppression of the basophil response to allergen during treatment with omalizumab is dependent on 2 competing factors. J Allergy Clin Immunol 130:1130-1135.e5. https:\/\/doi.org\/10.1016\/j.jaci.2012.05.038","journal-title":"J Allergy Clin Immunol"},{"key":"8902_CR91","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1159\/000321824","volume":"154","author":"Y Gernez","year":"2011","unstructured":"Gernez Y, Tirouvanziam R, Yu G, Ghosn EE, Reshamwala N, Nguyen T, Tsai M, Galli SJ, Herzenberg LA, Herzenberg LA, Nadeau KC (2011) Basophil CD203c levels are increased at baseline and can be used to monitor omalizumab treatment in subjects with nut allergy. Int Arch Allergy Immunol 154:318\u201327. https:\/\/doi.org\/10.1159\/000321824","journal-title":"Int Arch Allergy Immunol"},{"key":"8902_CR92","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.jaci.2012.05.039","volume":"130","author":"JH Savage","year":"2012","unstructured":"Savage JH, Courneya JP, Sterba PM, Macglashan DW, Saini SS, Wood RA (2012) Kinetics of mast cell, basophil, and oral food challenge responses in omalizumab-treated adults with peanut allergy. J Allergy Clin Immunol 130:1123-1129.e2. https:\/\/doi.org\/10.1016\/j.jaci.2012.05.039","journal-title":"J Allergy Clin Immunol"},{"key":"8902_CR93","doi-asserted-by":"publisher","first-page":"257","DOI":"10.5415\/apallergy.2014.4.4.257","volume":"4","author":"C Nilsson","year":"2014","unstructured":"Nilsson C, Nordvall L, Johansson SG, Nopp A (2014) Successful management of severe cow\u2019s milk allergy with omalizumab treatment and CD-sens monitoring. Asia Pac Allergy 4:257\u201360. https:\/\/doi.org\/10.5415\/apallergy.2014.4.4.257","journal-title":"Asia Pac Allergy"},{"key":"8902_CR94","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/cea.12862","volume":"47","author":"J Brandstrom","year":"2017","unstructured":"Brandstrom J, Vetander M, Lilja G, Johansson SG, Sundqvist AC, Kalm F, Nilsson C, Nopp A (2017) Individually dosed omalizumab: an effective treatment for severe peanut allergy. Clin Exp Allergy 47:540\u2013550. https:\/\/doi.org\/10.1111\/cea.12862","journal-title":"Clin Exp Allergy"},{"key":"8902_CR95","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.jaci.2017.03.028","volume":"140","author":"PA Frischmeyer-Guerrerio","year":"2017","unstructured":"Frischmeyer-Guerrerio PA, Masilamani M, Gu W, Brittain E, Wood R, Kim J, Nadeau K, Jarvinen KM, Grishin A, Lindblad R, Sampson HA (2017) Mechanistic correlates of clinical responses to omalizumab in the setting of oral immunotherapy for milk allergy. J Allergy Clin Immunol 140:1043-1053.e8. https:\/\/doi.org\/10.1016\/j.jaci.2017.03.028","journal-title":"J Allergy Clin Immunol"},{"key":"8902_CR96","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/mi.2012.5","volume":"5","author":"D Bedoret","year":"2012","unstructured":"Bedoret D, Singh AK, Shaw V, Hoyte EG, Hamilton R, DeKruyff RH, Schneider LC, Nadeau KC, Umetsu DT (2012) Changes in antigen-specific T-cell number and function during oral desensitization in cow\u2019s milk allergy enabled with omalizumab. Mucosal Immunol 5:267\u201376. https:\/\/doi.org\/10.1038\/mi.2012.5","journal-title":"Mucosal Immunol"},{"key":"8902_CR97","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/cea.13161","volume":"48","author":"A Abdel-Gadir","year":"2018","unstructured":"Abdel-Gadir A, Schneider L, Casini A, Charbonnier LM, Little SV, Harrington T, Umetsu DT, Rachid R, Chatila TA (2018) Oral immunotherapy with omalizumab reverses the Th2 cell-like programme of regulatory T cells and restores their function. Clin Exp Allergy 48:825\u2013836. https:\/\/doi.org\/10.1111\/cea.13161","journal-title":"Clin Exp Allergy"},{"key":"8902_CR98","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.jaci.2016.03.006","volume":"137","author":"SJ Galli","year":"2016","unstructured":"Galli SJ (2016) Toward precision medicine and health: opportunities and challenges in allergic diseases. J Allergy Clin Immunol 137:1289\u2013300. https:\/\/doi.org\/10.1016\/j.jaci.2016.03.006","journal-title":"J Allergy Clin Immunol"},{"key":"8902_CR99","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.immuni.2020.12.013","volume":"54","author":"K Golebski","year":"2021","unstructured":"Golebski K, Layhadi JA, Sahiner U, Steveling-Klein EH, Lenormand MM, Li RCY, Bal SM, Heesters BA, Vil\u00e0-Nadal G, Hunewald O, Montamat G, He FQ, Ollert M, Fedina O, Lao-Araya M, Vijverberg SJH, Maitland-van der Zee AH, van Drunen CM, Fokkens WJ, Durham SR, Spits H, Shamji MH (2021) Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response. Immunity 54:291-307.e7. https:\/\/doi.org\/10.1016\/j.immuni.2020.12.013","journal-title":"Immunity"},{"key":"8902_CR100","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s40272-020-00387-2","volume":"22","author":"A Licari","year":"2020","unstructured":"Licari A, Castagnoli R, Marseglia A, Olivero F, Votto M, Ciprandi G, Marseglia GL (2020) Dupilumab to treat type 2 inflammatory diseases in children and adolescents. Paediatr Drugs 22:295\u2013310. https:\/\/doi.org\/10.1007\/s40272-020-00387-2","journal-title":"Paediatr Drugs"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-021-08902-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-021-08902-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-021-08902-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T22:52:03Z","timestamp":1673304723000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-021-08902-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,22]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["8902"],"URL":"https:\/\/doi.org\/10.1007\/s12016-021-08902-0","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,22]]},"assertion":[{"value":"10 September 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"L.G. has been an investigator in clinical trials for AstraZeneca, MSD, and Novartis and reports grants or fees for consulting from AstraZeneca, GlaxoSmithKline, Novartis, and Sanofi-Regeneron and fees for consulting from Bayer, Chiesi, MSD, not related to the submitted work. M.M. declares no disclosure of interest. L.L.R. reports grants or consulting fees from Neovacs S.A. not related to the work submitted, and patents issued or pending relating to allergy diagnosis or therapy: 63\/079,686, PCT\/EP2021\/060829, WO2019197607 (A1) and WO2019228674 (A1).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}